What's in Anterogen Co., Ltd.'s pipeline?

Anterogen Co., Ltd. has 10 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 4 in Phase 2, 3 in Phase 1.

Which companies overlap with Anterogen Co., Ltd.'s portfolio?

Top competitors by shared drug class: Cell Biopeutics Resources Sdn Bhd, Hospital for Special Surgery, New York, Istituto Ortopedico Rizzoli, Kang Stem Biotech Co., Ltd., Medipost, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/anterogen-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Anterogen Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anterogen Co., Ltd. pipeline: 1 marketed, 0 filed, 2 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 4 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
ASC	ASC	marketed	Autologous stem cell therapy	Regenerative Medicine
Fibringlue	Fibringlue	phase 3		Other
ALLO-ASC-DFU	ALLO-ASC-DFU	phase 3	Allogeneic mesenchymal stem cell therapy	Dermatology / Wound Care

Therapeutic area mix

Other · 3
Dermatology / Wound Care · 1
Diabetes · 1
Regenerative Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Cell Biopeutics Resources Sdn Bhd · 1 shared drug class
Hospital for Special Surgery, New York · 1 shared drug class
Istituto Ortopedico Rizzoli · 1 shared drug class
Kang Stem Biotech Co., Ltd. · 1 shared drug class
Medipost, Inc. · 1 shared drug class
Mesoblast, Ltd. · 1 shared drug class
Pharmicell Co., Ltd. · 1 shared drug class
Regenexx, LLC · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Anterogen Co., Ltd.:

Cite this brief

Drug Landscape (2026). Anterogen Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/anterogen-co-ltd. Accessed 2026-06-10.